Revenio lays out new strategy, betting big on Visionix

iCare_ILLUME_doctor_looking_at_screen_and_patient

Revenio Group used its Capital Markets Day in Helsinki on September 15 to set out its strategy and financial targets for 2027-2029, its first full presentation since agreeing to acquire the French diagnostics group Visionix last April in a €290 million deal (see our earlier coverage). The event was held ...

Already an Eyewear Intelligence subscriber? Sign in here.

barrier_image_OIC

Subscribe today

Buying a membership today will give you:

  • Unlimited access to ewintelligence.com - all insight and analysis available online
  • Our executive edition of Eyewear Intelligence (Digital Edition) - the must-read for all decision-makers in the industry
  • Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments
  • Case studies and best practices on business challenges
  • Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry
  • Access to over 11,500 articles and analyses in the archive
  • Personal library to save articles and track your key content
  • Powerful search and intuitive navigation
  • Organisation-wide access across offices, people and devices

To continue reading this article register now.